DGX · Quest Diagnostics Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.90B | - | $2.82B | $2.76B | $2.65B | - | $2.49B | $2.40B | $2.37B | - |
| Cost of Revenue | $1.95B | - | $1.87B | $1.82B | $1.79B | - | $1.68B | $1.59B | $1.59B | - |
| Gross Profit | $942.00M | - | $949.00M | $943.00M | $863.00M | - | $811.00M | $804.00M | $771.00M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $504.00M | - | $501.00M | $486.00M | $476.00M | - | $448.00M | $416.00M | $440.00M | - |
| Total Operating Expenses | $2.50B | - | $2.43B | $2.32B | $2.31B | - | $2.16B | $2.04B | $2.07B | - |
| D&A | $147.00M | - | $142.00M | $143.00M | $140.00M | - | $125.00M | $117.00M | $116.00M | - |
| Operating Income | $399.00M | - | $386.00M | $438.00M | $346.00M | - | $330.00M | $355.00M | $300.00M | - |
| Interest Expense | - | - | - | - | - | - | - | $47.00M | $49.00M | - |
| Income Tax | $74.00M | - | $77.00M | $97.00M | $59.00M | - | $65.00M | $74.00M | $66.00M | - |
| Net Income | $252.00M | - | $245.00M | $282.00M | $220.00M | - | $226.00M | $229.00M | $194.00M | - |
| EPS - Basic | $2.27 | - | $2.18 | $2.51 | $1.97 | - | $2.01 | $2.05 | $1.74 | - |
| EPS - Diluted | $2.24 | - | $2.16 | $2.47 | $1.94 | - | $1.99 | $2.03 | $1.72 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $393.00M | $420.00M | $432.00M | $319.00M | $188.00M | $549.00M | $764.00M | $271.00M | $474.00M | $686.00M |
| Accounts Receivable | $1.59B | $1.41B | $1.46B | $1.42B | $1.40B | $1.30B | $1.38B | $1.32B | $1.32B | $1.21B |
| Inventory | $225.00M | $189.00M | $186.00M | $187.00M | $189.00M | $188.00M | $184.00M | $182.00M | $181.00M | $190.00M |
| Accounts Payable | - | $307.00M | - | - | - | $287.00M | - | - | - | $378.00M |
| Current Assets | $2.57B | $2.38B | $2.41B | $2.20B | $2.08B | $2.39B | $2.62B | $2.02B | $2.23B | $2.37B |
| Total Assets | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | $14.02B |
| Current Liabilities | $2.18B | $2.28B | $2.13B | $2.02B | $1.44B | $2.17B | $2.09B | $2.01B | $2.30B | $1.81B |
| Long-term Debt | - | $5.17B | - | - | - | $5.62B | $5.65B | - | - | $4.41B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $7.37B | $7.17B | $7.26B | $7.23B | $6.93B | $6.78B | $6.81B | $6.62B | $6.43B | $6.31B |
| Retained Earnings | $10.15B | $9.99B | $9.84B | $9.68B | $9.49B | $9.36B | $9.22B | $9.08B | $8.94B | $8.82B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $278.00M | - | - | - | $314.00M | - | - | - | $154.00M | - |
| Investing Cash Flow | ($152.00M) | - | - | - | ($115.00M) | - | - | - | ($213.00M) | - |
| Financing Cash Flow | ($152.00M) | - | - | - | ($561.00M) | - | - | - | ($153.00M) | - |
| CapEx | $114.00M | - | - | - | $117.00M | - | - | - | $104.00M | - |
| Free Cash Flow | $164.00M | - | - | - | $197.00M | - | - | - | $50.00M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 32.5% | - | 33.7% | 34.2% | 32.5% | - | 32.6% | 33.5% | 32.6% | - |
| Operating margin | 13.8% | - | 13.7% | 15.9% | 13.0% | - | 13.3% | 14.8% | 12.7% | - |
| EBITDA margin | 18.9% | - | 18.8% | 21.0% | 18.3% | - | 18.3% | 19.7% | 17.6% | - |
| Net margin | 8.7% | - | 8.7% | 10.2% | 8.3% | - | 9.1% | 9.6% | 8.2% | - |
| Free cash flow margin | 5.7% | - | - | - | 7.4% | - | - | - | 2.1% | - |
| FCF / Net income | 0.65 | - | - | - | 0.90 | - | - | - | 0.26 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 17.4% | - | 17.8% | 17.6% | 17.9% | - | 18.0% | 17.4% | 18.6% | - |
| Effective tax rate | 22.7% | - | 23.9% | 25.6% | 21.1% | - | 22.3% | 24.4% | 25.4% | - |
| Return on assets | 1.5% | - | 1.5% | 1.8% | 1.4% | - | 1.4% | 1.6% | 1.4% | - |
| Return on equity | 3.4% | - | 3.4% | 3.9% | 3.2% | - | 3.3% | 3.5% | 3.0% | - |
| Return on invested capital | - | - | - | - | - | - | 2.1% | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.18 | 1.04 | 1.13 | 1.09 | 1.44 | 1.10 | 1.25 | 1.00 | 0.97 | 1.31 |
| Quick ratio | 1.08 | 0.96 | 1.04 | 0.99 | 1.31 | 1.02 | 1.17 | 0.91 | 0.89 | 1.20 |
| Cash ratio | 0.18 | 0.18 | 0.20 | 0.16 | 0.13 | 0.25 | 0.37 | 0.13 | 0.21 | 0.38 |
| Leverage | ||||||||||
| Debt / Equity | - | 0.72 | - | - | - | 0.83 | 0.83 | - | - | 0.70 |
| Debt / Assets | - | 0.32 | - | - | - | 0.35 | 0.35 | - | - | 0.31 |
| Debt / EBITDA | - | - | - | - | - | - | 12.41 | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | 7.6x | 6.1x | - |
| Equity multiplier | 2.26 | 2.26 | 2.23 | 2.21 | 2.28 | 2.38 | 2.36 | 2.10 | 2.17 | 2.22 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.17 | - | 0.17 | 0.17 | 0.17 | - | 0.15 | 0.17 | 0.17 | - |
| Inventory turnover | 8.68 | - | 10.04 | 9.72 | 9.47 | - | 9.11 | 8.75 | 8.81 | - |
| Days sales outstanding | 200d | - | 189d | 188d | 193d | - | 202d | 201d | 204d | - |
| Days inventory outstanding | 42d | - | 36d | 38d | 39d | - | 40d | 42d | 41d | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 87.5x | - | 88.2x | 72.7x | 87.2x | - | 78.0x | 67.4x | 77.4x | - |
| P / B | 3.0x | - | 3.0x | 2.8x | 2.8x | - | 2.6x | 2.3x | 2.3x | - |
| P / S | 7.6x | - | 7.6x | 7.4x | 7.2x | - | 7.1x | 6.4x | 6.3x | - |
| EV / EBITDA | 39.5x | - | 40.0x | 34.4x | 39.0x | - | 49.3x | 31.9x | 34.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 9.2% | - | 13.2% | 15.2% | 12.1% | - | 8.4% | 2.5% | 1.5% | - |
| Revenue CAGR (3y) | 7.5% | - | 4.2% | 4.0% | 0.5% | - | -3.6% | -2.0% | -4.5% | - |
| Revenue CAGR (5y) | 1.3% | - | 0.2% | 8.6% | 7.8% | - | 5.7% | 4.5% | 4.6% | - |
| Gross profit growth (YoY) | 9.2% | - | 17.0% | 17.3% | 11.9% | - | 7.6% | 1.5% | 0.0% | - |
| Operating income growth (YoY) | 15.3% | - | 17.0% | 23.4% | 15.3% | - | -3.5% | 2.0% | -1.6% | - |
| Net income growth (YoY) | 14.5% | - | 8.4% | 23.1% | 13.4% | - | 0.4% | -2.6% | -4.0% | - |
| EPS growth (YoY) | 15.5% | - | 8.5% | 21.7% | 12.8% | - | 1.5% | -1.0% | -3.4% | - |
| EPS CAGR (3y) | 8.0% | - | -0.2% | 8.0% | -12.7% | - | -20.9% | -25.8% | -20.8% | - |
| EPS CAGR (5y) | -8.3% | - | -12.2% | 12.7% | 21.6% | - | 5.0% | 4.1% | 7.5% | - |
| FCF growth (YoY) | -16.8% | - | - | - | 294.0% | - | - | - | - | - |
| FCF CAGR (5y) | -24.0% | - | - | - | 3.7% | - | - | - | -26.2% | - |
| Book value growth (YoY) | 6.3% | 5.8% | 6.6% | 9.2% | 7.7% | 7.5% | 6.0% | 5.9% | 6.3% | 7.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$11.04B totalDiagnostic Information Services Business$10.79B · 97.7%
All Other Segments$250.00M · 2.3%
Peer comparison
Same SIC group: Services-Medical Laboratories
Comparing QUEST DIAGNOSTICS INC against the 5 most active filers in the same SIC group.
Dividends
$3.26/share trailing 12 months · +6.9% YoY
| Ex-date | Per share |
|---|---|
| Apr 6, 2026 | $0.8600 |
| Jan 13, 2026 | $0.8000 |
| Oct 3, 2025 | $0.8000 |
| Jul 7, 2025 | $0.8000 |
| Apr 7, 2025 | $0.8000 |
| Jan 14, 2025 | $0.7500 |
| Oct 4, 2024 | $0.7500 |
| Jul 8, 2024 | $0.7500 |
| Apr 5, 2024 | $0.7500 |
| Jan 16, 2024 | $0.7100 |
| Oct 5, 2023 | $0.7100 |
| Jul 10, 2023 | $0.7100 |
| Apr 6, 2023 | $0.7100 |
| Jan 17, 2023 | $0.6600 |
| Oct 3, 2022 | $0.6600 |
| Jul 5, 2022 | $0.6600 |
| Apr 5, 2022 | $0.6600 |
| Jan 18, 2022 | $0.6200 |
| Oct 4, 2021 | $0.6200 |
| Jul 6, 2021 | $0.6200 |
| Apr 6, 2021 | $0.6200 |
| Jan 19, 2021 | $0.5600 |
| Oct 5, 2020 | $0.5600 |
| Jul 7, 2020 | $0.5600 |